Kidney Neoplasm clinical trials at UC Davis
3 in progress, 2 open to eligible people
XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinoma and to identify the minimum safe and biologically active dose and the recommended dose (RD).
Sacramento, California and other locations
Project: Every Child for Younger Patients With Cancer
“A REGISTRY, ELIGIBILITY SCREENING, BIOLOGY AND OUTCOME STUDY”
open to eligible people ages up to 25 years
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Sacramento, California and other locations
Kidney Tumors in Younger Patients
Sorry, in progress, not accepting new patients
This research trial studies kidney tumors in younger patients. Collecting and storing samples of tumor tissue, blood, and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
Sacramento, California and other locations
Our lead scientists for Kidney Neoplasm research studies include Marcio H. Malogolowkin.
Last updated: